Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

6.3K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
6.3K
Bone Remodeling01:40

Bone Remodeling

40.9K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.9K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.6K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.6K
What is the Skeletal System?01:02

What is the Skeletal System?

58.6K
Overview
58.6K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

4.2K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

6.9K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of prior osteoporosis treatment on bone mineral density response to romosozumab.

Bone·2026
Same author

"Double trouble": the impact of iron infusion and antiresorptive therapy on calcium-phosphate homeostasis.

JBMR plus·2025
Same author

Bone Health in Patients With Type 2 Diabetes.

Journal of the Endocrine Society·2024
Same author

Bone metabolism in diabetes: a clinician's guide to understanding the bone-glucose interplay.

Diabetologia·2024
Same author

Associations of Type 2 Diabetes, Body Composition, and Insulin Resistance with Bone Parameters: The Dubbo Osteoporosis Epidemiology Study.

JBMR plus·2023
Same author

Factors associated with fragility fractures in type 2 diabetes: An analysis of the randomised controlled Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Diabetes/metabolism research and reviews·2023

Related Experiment Video

Updated: Mar 18, 2026

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
06:59

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model

Published on: September 8, 2023

3.8K

Secondary osteoporosis.

Angela Sheu1, Terry Diamond1

  • 1University of New South Wales, Sydney.

Australian Prescriber
|June 28, 2016
PubMed
Summary
This summary is machine-generated.

Secondary osteoporosis, often overlooked, can cause fragility fractures even without typical risk factors. Early identification through bone density testing and targeted investigations is crucial for managing this condition.

Keywords:
Z-scorebiopsy of bonebone densityfracture of boneosteoporosis

More Related Videos

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
07:12

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model

Published on: September 28, 2017

8.7K

Related Experiment Videos

Last Updated: Mar 18, 2026

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
06:59

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model

Published on: September 8, 2023

3.8K
Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
07:12

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model

Published on: September 28, 2017

8.7K

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Geriatrics

Background:

  • Secondary osteoporosis is less prevalent than primary osteoporosis.
  • It may manifest as fragility fractures in individuals lacking traditional osteoporosis risk factors.
  • Consideration is warranted when bone density Z-scores are -2.5 or lower.

Purpose of the Study:

  • To outline the diagnostic considerations for secondary osteoporosis.
  • To guide investigations for underlying causes of osteoporosis.
  • To emphasize the importance of baseline and advanced testing.

Main Methods:

  • Clinical assessment focusing on fracture site and associated clues.
  • Bone mineral metabolism testing (calcium, phosphate, alkaline phosphatase, 25-hydroxyvitamin D, parathyroid hormone).
  • Assessment of liver and kidney function, complete blood count, and thyroid-stimulating hormone levels.

Main Results:

  • Secondary osteoporosis suspicion arises from fragility fractures without risk factors or Z-scores ≤ -2.5.
  • Investigations should be tailored to suspected underlying causes.
  • Baseline tests cover bone/mineral metabolism, organ function, and thyroid status.

Conclusions:

  • Prompt recognition of secondary osteoporosis is vital for appropriate management.
  • A systematic approach to investigation, guided by clinical presentation, is recommended.
  • Further testing may be necessary for patients with severe osteoporosis.